background

Raltegravir 13C D3

Raltegravir 13C D3 Watermark

Raltegravir 13C D3

CAT No:CL-RGVR-37
CAS No:NA
Mol.F:C1913CH18D3FN6O5
Mol.Wt.:448.4
Chemical Name:N-(2-(4-((4-fluorobenzyl)carbamoyl)-5-hydroxy-1-(methyl-13C-d3)-6-oxo-1,6-dihydropyrimidin-2-yl)propan-2-yl)-5-methyl-1,3,4-oxadiazole-2-carboxamide
Inventory Status:Custom synthesis

This impurity is related to Raltegravir 13C D3 is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.

Raltegravir 13C D3 is used as a reference standard in analytical research. It ensures consistency of formulations.

Chemical Name:N-(2-(4-((4-fluorobenzyl)carbamoyl)-5-hydroxy-1-(methyl-13C-d3)-6-oxo-1,6-dihydropyrimidin-2-yl)propan-2-yl)-5-methyl-1,3,4-oxadiazole-2-carboxamide
Country of Origin: India
Product Category: Impurity Reference Standard
API NAME: Raltegravir
Molecular Formula: C1913CH18D3FN6O5
Molecular Weight: 448.4
Storage: Store in a cool, dry place.

Document